Navigation Links
GeoVax Labs Reports 2012 First Quarter Financial Results
Date:5/15/2012

ATLANTA, May 15, 2012 /PRNewswire/ -- GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced its financial results for the three months ended March 31, 2012 and provided a business update.

"We are delighted with recent developments that have strengthened and advanced our HIV/AIDS vaccine program," said Chairman of the Board David Dodd. "Our Phase 1/2 therapeutic vaccine trial continues to enroll patients and we expect full enrollment by the end of 2012. The HIV Vaccine Trials Network (HVTN) continues toward the goal of compiling the data for the Phase 2a trial of our preventive vaccine by the end of 2012 and recently opened a new Phase 1 trial of the next generation of our preventive vaccine, which utilizes granulocyte-macrophase colony-stimulating factor (GM-CSF) as an adjuvant to boost the immune response. We are gratified that the NIH-supported HVTN continues to recognize the potential life-saving value of our vaccine technology and has committed substantial resources toward advancing our clinical progress. Most important, we have a highly competent and dedicated team, focused on excellence in execution related to our ongoing development programs."

Robert T. McNally, PhD, GeoVax President and CEO, remarked, "We are particularly pleased with the outstanding preclinical results we recently reported for our next generation preventive vaccine, which co-expresses GM-CSF as an adjuvant in the DNA vaccine used to prime the immune system. Our studies demonstrated an unprecedented 90% reduction in per exposure risk of transmission for the E660 strain of SIV (simian HIV) and 72% reduction in per exposure risk of transmission for SIV251, the most potent strain of SIV used in non-human primate models. These are extremely rigorous models, with the primates receiving repeated weekly exposures to SIV of up to 300 times the amount one would expect to see in humans. Our data ind
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. GeoVax Labs CEO Update Letter to Shareholders
2. GeoVax Labs First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
3. GeoVax Phase 2a Clinical Trial Completes Enrollment
4. GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
5. GeoVax Labs, Inc. Announces Second Quarter Financial Results
6. GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress
7. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
8. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
9. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
10. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
11. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 2015 Amgen (NASDAQ: AMGN ) ... 3, global, randomized, placebo-controlled trials evaluating AMG 416, ... hyperparathyroidism (SHPT) in patients with chronic kidney disease ... endpoint, demonstrating that a greater proportion of patients ... than 30 percent reduction in parathyroid hormone (PTH) ...
(Date:5/28/2015)... and HOUSTON , May 28, 2015 /PRNewswire/ ... today reported financial results for the second quarter and three ... otherwise, are expressed in Canadian dollars and in accordance with ... ESSA recorded a net loss of $5.9 ... March 31, 2015 (Q2-2015), compared to a net loss of ...
(Date:5/28/2015)... , May 28, 2015  IRIDEX Corporation (NASDAQ: IRIX ... Officer James H. Mackaness is scheduled to present ... at 9:00 am PT in Los Angeles ... may be accessed on the Event Calendar of the Investors ... of the webcast will be available shortly after the conclusion ...
Breaking Medicine Technology:Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 4Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 6Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 7Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5
... Oct. 5 Osseon Therapeutics, Inc. announced its ... North American Spine Society,s (NASS) annual meeting in ... facilitate treatment of vertebral compression fractures (VCFs) that ... fibrotic metastases.  The Osseoflex DR Steerable Bone Drill ...
... SUNNYVALE, Calif., Oct. 5 Accuray Incorporated (Nasdaq: ... of radiosurgery, announced today that the company was awarded a ... U.S. Government to be used toward further development of a ... grant will fund the development of a next generation, compact ...
Cached Medicine Technology:Osseon® Therapeutics Introduces New Osseoflex® DR Steerable Bone Drill 2Accuray Awarded $1 Million Grant by U.S. Government 2Accuray Awarded $1 Million Grant by U.S. Government 3
(Date:5/29/2015)... York (PRWEB) May 29, 2015 World ... patented products, announces that it has signed a 10 ... technology patent that aims to let people learn about ... in real time. , "This is an exciting day ... " said Scott J. Cooper, CEO and Creative Director ...
(Date:5/29/2015)... New York, NY (PRWEB) May 29, 2015 ... readers on the “beauty of protection”. Skin Health ... through USA Today within the markets of New York, ... reach an estimated 750,000 readers. Its digital counterpart will ... online content hubs. To read more the Skin Health ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 The ... provides comprehensive information on the therapeutic development for ... of muscles in the body, leading to many ... pipelines by identifying new targets and MOAs to ... H1 2015 pipeline review of Axillary Hyperhidrosis with ...
(Date:5/29/2015)... Hollywood, Florida (PRWEB) May 29, 2015 ... and Bodybuilding.com teamed up to create an all new, ... supplements are a formulated with the latest and greatest, ... researched and proven to be effective. The 24/7 Series ... runners, to cross-fitters and even the casual fitness enthusiasts. ...
(Date:5/29/2015)... The annual aesthetic meeting, put on by the American ... from May 14-19th. This global event sets a gold ... world; dedicating itself exclusively to cosmetic medicine. Dr. Paul ... to attend this year’s meeting. , Among the classes ... given the honor of sitting at the presenter’s table during ...
Breaking Medicine News(10 mins):Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5Health News:Mediaplanet Launches “Skin Health” Campaign Featuring Colorescience 2Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 2Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 3
... choose to decorate the,Christmas tree, light the menorah, or ... can be an extremely stressful time for,couples in inter-faith ... to celebrate can strain your relationship and,lead to conflict ... on your religious backgrounds and level of dedication to ...
... The American Academy,of Orthopaedic Surgeons (AAOS) has approved and ... Carpal Tunnel Syndrome.", "Carpal Tunnel Syndrome, otherwise known ... upper extremity. It affects up to ten percent of,the ... thought to be caused,by increased pressure on the median ...
... of its commitment to providing the industry,s most aggressive defense, The ... liability in the U.S., is rolling out litigation education retreats for ... , ... Napa, Calif. (Vocus) October 27, 2008 -- As ...
... systems for HH-60M Black Hawk ... helicopter, ... largest air medical transportation company in the,world, today announced its Products Division ... Company for production of 48,HH-60M Black Hawk Multi-Mission Medevac Interior Systems. Production ...
... October 27, 2008 Is schizophrenia a disorder of ... for many years was that schizophrenia was a glutamate ... as well. The study by Karlsson et al., ... Psychiatry , reinforces this point with new data about ...
... Digital ID for Travelers Makes Doctor Visits Abroad Even ... a global health and,safety services company, today announced the ... card. My Digital ID enables HTH,members to access all ... mobile phone. Global travelers can rely on direct access ...
Cached Medicine News:Health News:He's Jewish, I'm Catholic, It's December. Now What? 2Health News:AAOS Issues New Treatment Guidelines for Carpal Tunnel Syndrome 2Health News:The Doctors Company Launches Litigation Education Retreats to Assist Physicians Involved in Medical Litigation 2Health News:Air Methods Receives $17 Million Contract from Sikorsky Aircraft Company 2Health News:Glutamate: Too much of a good thing in schizophrenia? 2Health News:HTH Worldwide Unveils First Digital Healthcare Card 2
... self-adjusting adaptability to fit almost every operating ... angling at the sit of fixation to ... it to be titled to any position ... a simple adjustment of the 3/D Swinger ...
Inquire...
Stainless steel construction to withstand sterilization modalities (EtO, Steris, and Sterrad)...
Stainless steel construction to withstand sterilization modalities (EtO, Steris, and Sterrad) Wide angle of view...
Medicine Products: